Obesity and changes in urine albumin/creatinine ratio in patients with type 2 diabetes: The DEMAND Study

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 20, Issue 2, 2010, Pages 110-116

  Rossi, M C E ^a   Nicolucci, A ^a   Pellegrini, F ^a   Comaschi, M ^b   Ceriello, A ^c   Cucinotta, D ^d   Giorda, C ^e   Pomili, B ^a   Valentini, U ^f   Vespasiani, G ^g   De Cosmo, S ^h  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b Ospedale La Colletta   (Italy)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF MESSINA   (Italy)

^e ASL TO5   (Italy)

^f Diabetologic Unit   (Italy)

^g Madonna del Soccorso Hospital   (Italy)

^h Unit of Endocrinology   (Italy)

Author keywords

Albumin excretion rate; Obesity; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; CREATININE;

AGED; ALBUMINURIA; ARTICLE; BODY MASS; CLINICAL TRIAL; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; HUMAN; ITALY; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTPATIENT DEPARTMENT; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME; URINE; WAIST CIRCUMFERENCE;

AGED; ALBUMINURIA; AMBULATORY CARE FACILITIES; BIOLOGICAL MARKERS; BODY MASS INDEX; CREATININE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; HUMANS; ITALY; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; WAIST CIRCUMFERENCE;

EID: 75549089842     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.02.013     Document Type: Article

References (27)

1. Ritz E. Heart and kidney: fatal twins?. Am J Med 119 5 Suppl. 1 (2006) S31-S39
2. Bianchi C., Penno G., Malloggi L., Barontini R., Corfini M., Giovannitti M.G., et al. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome. Nutr Metab Cardiovasc Dis 18 (2008) 31-38
3. Bo S., Ciccone G., Gancia R., Rosato R., Grassi G., Merletti F., et al. Mortality within the first 10 years of the disease in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 16 (2006) 8-12
4. Rossi M.C., Nicolucci A., Pellegrini F., Comaschi M., Ceriello A., Cucinotta D., et al. Identifying patients with type 2 diabetes at high risk of microalbuminuria: results of the DEMAND (Developing Education on Microalbuminuria for Awareness of reNal and cardiovascular risk in Diabetes) Study. Nephrol Dial Transplant 23 (2008) 1278-1284
5. Franciosi M., Pellegrini F., Sacco M., De Berardis G., Rossi M.C., Strippoli G.F., et al. IGLOO (Impaired Glucose tolerance, and Long-term Outcomes Observational Study) Study Group. Identifying patients at risk for microalbuminuria via interaction of the components of the metabolic syndrome: a cross-sectional analytic study. Clin J Am Soc Nephrol 2 (2007) 984-991
6. Palaniappan L., Carnethon M., and Fortmann S.P. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 16 (2003) 952-958
7. Chandie Shaw P.K., Berger S.P., Mallat M., Frölich M., Dekker F.W., and Rabelink T.J. Central obesity is an independent risk factor for albuminuria in nondiabetic South Asian subjects. Diabetes Care 30 (2007) 1840-1844
8. Hsu C.Y., McCulloch C.E., Iribarren C., Darbinian J., and Go A.S. Body mass index and risk for end-stage renal disease. Ann Intern Med 144 (2006) 21-28
9. Retnakaran R., Cull C.A., Thorne K.I., Adler A.I., and Holman R.R.U.K.P.D.S. Study Group. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes 55 (2006) 1832-1839
10. Cignarelli M., and Lamacchia O. Obesity and kidney disease. Nutr Metab Cardiovasc Dis 17 (2007) 757-762
11. Bello A.K., de Zeeuw D., El Nahas M., Brantsma A.H., Bakker S.J., de Jong P.E., et al. Impact of weight change on albuminuria in the general population. Nephrol Dial Transplant 22 (2007) 1619-1627
12. de Boer I.H., Sibley S.D., Kestenbaum B., Sampson J.N., Young B., Cleary P.A., et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 18 (2007) 235-243
13. Steinberg H.O., Chaker H., Leaming R., Johnson A., Brechtel G., and Baron A.D. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97 (1996) 2601-2610
14. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-κB. Nat Med 11 (2005) 183-190
15. Yudkin J.S. Inflammation, obesity, and the metabolic syndrome. Horm Metab Res 39 (2007) 707-709
16. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation (1999), World Health Organization, Geneva
17. Gerstein H.C., Mann J.F., Yi Q., Zinman B., Dinneen S.F., Hoogwerf B., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
18. Wachtell K., Ibsen H., Olsen M.H., Borch-Johnsen K., Lindholm L.H., Mogensen C.E., et al. Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139 (2003) 901-906
19. Arnlov J., Evans J.C., Meigs J.B., Wang T.J., Fox C.S., Levy D., et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation 112 (2005) 969-975
20. Ruggenenti P., and Remuzzi G. Time to abandon microalbuminuria?. Kidney Int 70 (2006) 1214-1222
21. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
22. Morales E., Valero M.A., Leon M., Hernandez E., and Praga M. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 41 (2003) 319-327
23. Solerte S.B., Fioravanti M., Schifino N., and Ferrari E. Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes 13 (1989) 203-211
24. Serra A., Granada M.L., Romero R., Bayés B., Cantón A., Bonet J., et al. The effect of bariatric surgery on adipocytokines, renal parameters and other cardiovascular risk factors in severe and very severe obesity: 1-year follow-up. Clin Nutr 25 (2006) 400-408
25. Tong P.C., Lee Z.S., Sea M.M., Chow C.C., Ko G.T., Chan W.B., et al. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes. Arch Intern Med 162 (2002) 2428-2435
26. Gansevoort R.T., Verhave J.C., Hillege H.L., Burgerhof J.G., Bakker S.J., de Zeeuw D., et al. for the PREVEND Study Group. The validity of screening based on spot morning urine samples to detect subjects with microalbuminuria in the general population. Kidney Int 94 Suppl (2005) S28-S35
27. Strippoli G.F., Craig M., Deeks J.J., Schena F.P., and Craig J.C. Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review. BMJ 329 (2004) 828-838